G-Quadruplex Targeting in the Fight against Viruses: An Update

被引:57
|
作者
Ruggiero, Emanuela [1 ]
Zanin, Irene [1 ]
Terreri, Marianna [1 ]
Richter, Sara N. [1 ]
机构
[1] Univ Padua, Dept Mol Med, I-35121 Padua, Italy
关键词
G-quadruplexes; virus; targeting; G-quadruplex ligands; antiviral therapy; CATIONIC PORPHYRIN TMPYP4; TELOMERIC G-QUADRUPLEX; RNA-POLYMERASE I; FORMING SEQUENCES; INTERACTIVE AGENTS; PROMOTER REGION; NUCLEAR ANTIGEN; IMMUNE EVASION; SMALL-MOLECULE; UNIQUE DOMAIN;
D O I
10.3390/ijms222010984
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
G-quadruplexes (G4s) are noncanonical nucleic acid structures involved in the regulation of key cellular processes, such as transcription and replication. Since their discovery, G4s have been mainly investigated for their role in cancer and as targets in anticancer therapy. More recently, exploration of the presence and role of G4s in viral genomes has led to the discovery of G4-regulated key viral pathways. In this context, employment of selective G4 ligands has helped to understand the complexity of G4-mediated mechanisms in the viral life cycle, and highlighted the possibility to target viral G4s as an emerging antiviral approach. Research in this field is growing at a fast pace, providing increasing evidence of the antiviral activity of old and new G4 ligands. This review aims to provide a punctual update on the literature on G4 ligands exploited in virology. Different classes of G4 binders are described, with emphasis on possible antiviral applications in emerging diseases, such as the current COVID-19 pandemic. Strengths and weaknesses of G4 targeting in viruses are discussed.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] On the Road to Fight Cancer: The Potential of G-Quadruplex Ligands as Novel Therapeutic Agents
    Alessandrini, Irene
    Recagni, Marta
    Zaffaroni, Nadia
    Folini, Marco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [22] Functional G-Quadruplex Binding Molecules
    Nagatsugi, Fumi
    Onizuka, Kazumitsu
    CHEMISTRY LETTERS, 2020, 49 (07) : 771 - 780
  • [23] Fluorescent Probes for G-Quadruplex Structures
    Vummidi, Balayeshwanth R.
    Alzeer, Jawad
    Luedtke, Nathan W.
    CHEMBIOCHEM, 2013, 14 (05) : 540 - 558
  • [24] Design of Modular G-quadruplex Ligands
    Duarte, Ana Rita
    Cadoni, Enrico
    Ressurreicao, Ana S.
    Moreira, Rui
    Paulo, Alexandra
    CHEMMEDCHEM, 2018, 13 (09) : 869 - 893
  • [25] One Terminal Guanosine Flip of Intramolecular Parallel G-Quadruplex: Catalytic Enhancement of G-Quadruplex/Hemin DNAzymes
    Cao, Yanwei
    Li, Wenjing
    Gao, Tian
    Ding, Pi
    Pei, Renjun
    CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (39) : 8631 - 8638
  • [26] New Ruthenium-Based Probes for Selective G-Quadruplex Targeting
    Piraux, Guillaume
    Bar, Laure
    Abraham, Michael
    Lavergne, Thomas
    Jamet, Helene
    Dejeu, Jerome
    Marcelis, Lionel
    Defrancq, Eric
    Elias, Benjamin
    CHEMISTRY-A EUROPEAN JOURNAL, 2017, 23 (49) : 11872 - 11880
  • [27] Beyond small molecules: targeting G-quadruplex structures with oligonucleotides and their analogues
    Cadoni, Enrico
    De Paepe, Lessandro
    Manicardi, Alex
    Madder, Annemieke
    NUCLEIC ACIDS RESEARCH, 2021, 49 (12) : 6638 - 6659
  • [28] G-quadruplex ligands: Mechanisms of anticancer action and target binding
    Ilyinsky, N. S.
    Varizhuk, A. M.
    Beniaminov, A. D.
    Puzanov, M. A.
    Shchyolkina, A. K.
    Kaluzhny, D. N.
    MOLECULAR BIOLOGY, 2014, 48 (06) : 778 - 794
  • [29] Targeting a c-MYC G-quadruplex DNA with a fragment library
    Nasiri, Hamid R.
    Bell, Neil M.
    McLuckie, Keith I. E.
    Husby, Jarmila
    Abell, Chris
    Neidle, Stephen
    Balasubramanian, Shankar
    CHEMICAL COMMUNICATIONS, 2014, 50 (14) : 1704 - 1707
  • [30] Targeting Canine KIT Promoter by Candidate DNA G-Quadruplex Ligands
    Zorzan, Eleonora
    Da Ros, Silvia
    Giantin, Mery
    Shahidian, Lara Zorro
    Guerra, Giorgia
    Palumbo, Manlio
    Sissi, Claudia
    Dacasto, Mauro
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 367 (03) : 461 - 472